V. Lundström

No ORCID on file · 4 papers in corpus
article 1985
The effect of a prostaglandin synthetase inhibitor on the hormonal profile and the endometrium in women
·doi:10.1016/0002-9378(85)90304-7

A prostaglandin synthetase inhibitor, naproxen, was given continuously throughout the menstrual cycle at a dose of 250 mg twice daily to 10 healthy fertile women (group 1) and at a dose of 1000 mg per day to eight women in the secretory pha…

article 1979
ENDOGENOUS PROSTAGLANDINS IN DYSMENORRHEA AND THE EFFECT OF PROSTAGLANDIN SYNTHETASE INHIBITORS (PGSI) ON UTERINE CONTRACTILITY
·doi:10.3109/00016347909157790

The plasma concentration of 13,14-dihydro-PGF2 alpha during menstruation were determined by gas chromatography in 6 non-dysmenorrheic and 10 dysmenorrheic women. Nine out of 10 dysmenorrheic women were found to have increased levels (greate…

article 1978
Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women
·doi:10.1016/0002-9378(78)90320-4

The concentrations of prostaglandin F2alpha 15-keto-13, 14-dihydro-PGF2alpha, and 13,14-dihydro-PGF2alpha were determined in plasma and in endometrial specimens taken from both dysmenorrheic and normal women at the time of their menstruatio…

article 1977
The Myometrial Response to Intra‐Uterine Administration of PGF2α and PGE2 in Dysmenorrheic Women
·doi:10.3109/00016347709162115

Serial recordings of uterine contractility during different phases of the menstrual cycle were carried out in five dysmenorrheic women, and in two subjects during the acute stage of severe dysmenorrheic pain. The sensitivity and reactivity …